Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

Describe the epidemiology of COVID-19, including prevalence, morbidity, and viral ecology of SARS-CoV-2
Define the effectiveness of COVID-19 vaccination, including the potential clinical benefits of the first seasonal monovalent vaccine
Discuss how the response to the COVID-19 pandemic may inform approaches to minimizing harm

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Suggested Additional Reading:

Vaccine Effectiveness Studies, Centers for Disease Control and Prevention, updated Dec. 14, 2023. Accessible at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/how-they-work.html, access 1/29/2024.
Markov, P.V., Ghafari, M., Beer, M. et al. The evolution of SARS-CoV-2. Nat Rev Microbiol 21, 361–379 (2023). https://doi.org/10.1038/s41579-023-00878-2

Joint Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™.Each physician should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:

Graham Snyder, MD, MS — Associate Professor of Medicine, Division of Infectious Diseases
Medical Director, Infection Prevention and Hospital Epidemiology, University of Pittsburgh School of Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Mark Geraci, MD — Interim Department Chair, Department of Medicine, Professor of Medicine
Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh School of Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.